CITI Training Practice Exam

Question: 1 / 400

21 CFR 312.57 pertains to which aspect of drug development?

Labeling and packaging

Recordkeeping requirements

21 CFR 312.57 pertains to recordkeeping requirements in drug development. This means that it outlines the regulations for maintaining accurate and complete records throughout the entire drug development process. It is important for companies to adhere to these regulations in order to ensure the safety and efficacy of their drugs. While labeling and packaging, safety reporting, and quality control are all important aspects of drug development, they are not specifically addressed in 21 CFR 312.57. Therefore, they are incorrect choices.

Get further explanation with Examzify DeepDiveBeta

Safety reporting

Quality control

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy